Pathogenesis of Burkitt lymphoma: Expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts
Open Access
- 1 April 1987
- Vol. 49 (2) , 161-170
- https://doi.org/10.1016/0092-8674(87)90556-3
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Selective extraction of polyoma DNA from infected mouse cell culturesPublished by Elsevier ,2004
- The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic miceCell, 1986
- Defective Regulation of Epstein–Barr Virus Infection in Patients with Acquired Immunodeficiency Syndrome (AIDS) or AIDS-Related DisordersNew England Journal of Medicine, 1986
- An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cellsCell, 1985
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985
- Posttranscriptional mechanisms are responsible for accumulation of truncated c-myc RNAs in murine plasma cell tumorsCell, 1985
- Non-Hodgkin's Lymphoma in 90 Homosexual MenNew England Journal of Medicine, 1984
- Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphomaNature, 1984
- Chromosome translocation can occur on either side of the c-myc oncogene in Burkitt lymphoma cellsNature, 1984
- Burkitt's lymphoma outside the known endemic areas of Africa and New GuineaInternational Journal of Cancer, 1967